Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 21, 2005
- Accepted for publication February 11, 2006
- Published online July 3, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Bernard M. Tijink 1 ,
- Dario Neri 2 ,
- C. René Leemans 1 ,
- Marianne Budde 1 ,
- Ludger M. Dinkelborg 3 ,
- Marijke Stigter-van Walsum 1 ,
- Luciano Zardi 4 and
- Guus A.M.S. van Dongen 1
- 1Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands; 2Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland; 3Research Laboratories of Schering AG, Berlin, Germany; and 4Laboratory of Innovative Therapy, Advanced Biotechnology Center, Istuto Giannina Gaslini, Genova, Italy
- For correspondence or reprints contact: Guus A.M.S. van Dongen, PhD, Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. E-mail: gams.vandongen{at}vumc.nl
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer
- Radretumab Radioimmunotherapy in Patients with Brain Metastasis: A 124I-L19SIP Dosimetric PET Study
- Advances in Immuno-Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer
- Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
- Differential Splicing Generates New Transmembrane Receptor and Extracellular Matrix-related Targets for Antibody-based Therapy of Cancer
- Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
- Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
- Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin
- The Antibody-Mediated Targeted Delivery of Interleukin-15 and GM-CSF to the Tumor Neovasculature Inhibits Tumor Growth and Metastasis
- Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis